Integer price to free cash flow ITGR

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 38.4×
10-year median: 25.5×
Against its 10-year history: 73rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 13.5× to 186×
Peer median: 20.7×

Integer's price to free cash flow is 38.4× as of Oct 23, 2026.

That is above its ten-year median of 25.5×, higher than on 73% of days in the last ten years.

Over that time it ranged from 13.5× in Feb 2018 to 186× in Jun 2023.

The median for 6 medical device stocks of a similar size is 20.7×.

Price to free cash flow over time

median 25.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	38.4×	22.2×	41.2×
2025	22.8×	18.6×	64.4×
2024	60.9×	50.3×	66.7×
2023	53.5×	42.6×	186×
2022	61.0×	17.4×	65.2×
2021	19.2×	18.0×	25.9×
2020	25.4×	14.3×	27.4×
2019	21.7×	18.4×	30.7×
2018	22.8×	13.5×	28.4×
2017	13.9×	13.9×	27.0×
2016	65.3×	59.4×	88.3×
2015	91.8×	16.0×	104×
2014	16.3×	14.7×	57.3×
2013	55.3×	16.9×	226×
2012	16.4×	12.7×	16.5×

Against its peers

Companies in Medical - Devices nearest Integer's size, closest first, today.

Company	Price to free cash flow
ITGRInteger	38.4×
LIVNLivaNova	30.1×
TMDXTransMedics	31.0×
CNMDCONMED	11.0×
ZBHZimmer Biomet	12.3×
DXCMDexCom	20.9×
GEHCGE HealthCare Technologies	20.4×
Peer median	20.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Integer

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.